CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for HUTCHMED (China) Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

HUTCHMED (China) Ltd
48Th Floor, Cheung Kong Center
2 Queen's Road Central
Phone: +852 21281188p:+852 21281188 Hong Kong Ticker: 1313
Business Summary
HUTCHMED (China) Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
2099 Food preparations, not elsewhere classified
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board DanEldar 70 5/17/2024 8/1/2016
Chief Executive Officer, Chief Scientific Officer, Executive Director WeiguoSu 66 3/4/2022 3/27/2017
Chief Financial Officer, Executive Director Chig FungCheng 57 2/18/2011 2/18/2011
11 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
HUTCHMED INTERNATIONAL CORPORATION 25A VREELAND ROAD FLORHAM PARK NJ

Business Names
Business Name
0013
13
HCM
14 additional Business Names available in full report.

General Information
Number of Employees: 1,970 (As of 6/30/2024)
Outstanding Shares: 871,601,095 (As of 11/29/2024)
Stock Exchange: HKG
Fax Number: +852 21281778


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024